Skip to main content

Research Needs for Biologically Based Risk Assessment

  • Chapter
Biologically Based Methods for Cancer Risk Assessment

Abstract

Because of gaps in our current scientific understanding of the cancer-causing process, human risk assessment for chemicals which have demonstrated carcinogenicity in rodents requires the use of a series of judgmental decisions on numerous unresolved scientific issues. Major assumptions are based on the necessity to extrapolate experimental results (1) across species from mice or rats to humans, (2) from the high-dose regions to which animals are exposed in the laboratory to the low-dose regions to which humans are exposed in the environment, and (3) across routes of administration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andersen, M.E., H.J. Clewell, III, M.L. Gargas, F.A. Smith, and R.H. Reitz. (1987). Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87: 185–205.

    Article  PubMed  CAS  Google Scholar 

  • Cohen, S.M., R.E. Greenfield, and L.B. Ellwein. (1983). Multistage carcinogenesis in the urinary bladder. Environ. Health Perspectives 49: 202–215.

    Article  Google Scholar 

  • Ellwein, L.B., and S.M. Cohen. (1986). Modeling of cellular dynamics in carcinogenesis risk assessment. Eppley Institute for Research on Cancer, University of Nebraska. ( Unpublished manuscript).

    Google Scholar 

  • Ellwein, L.B. and S.M. Cohen. (1988). Cellular dynamics model of experimental bladder cancer: Analysis of the effect of sodium saccharin in the rat. Risk Analysis 8: 215–222.

    Article  PubMed  CAS  Google Scholar 

  • Moolgavkar, S.H., N.E. Day, and R.G. Stevens. (1980). Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. J. National Cancer Institute 65 (3): 559–569.

    CAS  Google Scholar 

  • Moolgavkar, S.H. and A.G. Knudson, Jr. (1981)., Mutation and cancer: A model for human carcinogenesis. J. Natl. Cancer Inst. 66: 1037–1052.

    PubMed  CAS  Google Scholar 

  • Moolgavkar, S.H. (1986). Carcinogenesis modeling: From molecular biology to epidemiology. Ann. Rev. Public Health 7: 151–169.

    Article  CAS  Google Scholar 

  • Moolgavkar, S.H., A. Dewanji and D.J. Venzen. (1988). A stochastic two-stage model for cancer risk assessment I: The hazard function and the probability of tumor. Risk Analysis in press).

    Google Scholar 

  • Paustenbach, D.J., M.E. Andersen, H.J. Clewell, III, and M.L. Gargas. (1988). A physiologically based pharmacokinetic model for inhaled carbon tetrachloride. Toxicol. Appl. Pharmacol. (in press).

    Google Scholar 

  • Ramsey, J.C., and M.E. Andersen. (1984). A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73: 159–175.

    Article  PubMed  CAS  Google Scholar 

  • Reitz, R. H., R.J. Nolan, and A.M. Schumann. (1987). Organohalides. In Proceedings of the National Academy of Science Workshop on Pharmacokinetics, Safe Drinking Water Committee, Subcommittee on Pharmacokinetics, Board on Environmental Studies and Toxicology, National Research Council.

    Google Scholar 

  • Reitz, R.H., J.N. McDougal, M.W. Himmelsteín, R.J. Nolan and A.M. Schumann. (1988). Physiologically-based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose and dose route extrapolations. Toxicol. Appl. Pharmacol. (in press).

    Google Scholar 

  • Scherer, E., and P. Emmelot. (1976). Kinetics of induction and growth of enzyme-deficient islands involved in hepatocarcinogenesis. Cancer Res. 36: 2544–2554.

    PubMed  CAS  Google Scholar 

  • Thorslund, T.W., C.C. Brown and G. Charnley. (1987). Biologically motivated cancer risk models. Risk Analysis 7: 109–119.

    Article  PubMed  CAS  Google Scholar 

  • Travis, C.C. (1987). Interspecies and Dose-Route Extrapolations. In Proceedings of the National Academy of Science Workshop on Pharmacokinetics, Safe Drinking Water Committee, Subcommittee on Pharmacokinetics, Board on Environmental Studies and Toxicology, National Research Council.

    Google Scholar 

  • Ward, R.C., C.C. Travis, D.M. Hetrick, M.W. Andersen, and M.L. Gargas. (1988). Pharmacokinetics of tetrachloroethylene. Toxicol. Appl. Pharmacol. 93: 108–117.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Travis, C.C. (1989). Research Needs for Biologically Based Risk Assessment. In: Travis, C.C. (eds) Biologically Based Methods for Cancer Risk Assessment. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5625-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5625-7_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5627-1

  • Online ISBN: 978-1-4684-5625-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics